Shenzhen BioX Medical Co., Ltd. stands as a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is strategically headquartered in Shenzhen, China—a global nexus for biotechnology innovation, advanced medical device development, and precision manufacturing.
Operating a state-of-the-art facility exceeding 9,000 square meters with a dedicated workforce of over 200 industry specialists, BioX Medical integrates cutting-edge R&D with rigorous quality standards to serve hospitals, research institutions, and public health organizations on a global scale.
Leveraging Shenzhen's unique supply chain, we provide rapid prototyping and large-scale production of qPCR systems with unmatched lead times.
Our systems utilize premium CCD sensors and multi-channel fluorescence detection to ensure sensitivity levels down to single-copy detection.
We provide deep technical documentation and open-system compatibility, allowing labs to customize assays for emerging pathogens.
Compliance with ISO 13485 and CE IVD ensures that our diagnostic platforms meet the rigorous safety and performance requirements of the EU and North America.
The global molecular diagnostics market is shifting from centralized laboratory testing toward Point-of-Care Testing (POCT) and Integrated Automation. Real-Time PCR (qPCR) remains the gold standard due to its speed, accuracy, and cost-effectiveness. Key trends include the integration of Artificial Intelligence (AI) for automated curve analysis, which eliminates human error in interpreting Cq values.
Furthermore, the demand for multiplexing capabilities has surged. Modern clinics require systems that can detect 4-6 different pathogens in a single reaction well—crucial for respiratory panels and gastrointestinal screenings. BioX Medical addresses these needs by developing systems like the BNP-32 and Seq24, which combine nucleic acid extraction with high-throughput analysis, streamlining the "sample-to-result" workflow.
Our solutions encompass more than just hardware. We provide Macro Industry Solutions including laboratory workflow optimization, cold-chain reagent logistics support, and cloud-based data management for multi-site epidemiological monitoring. This holistic approach ensures that high-volume testing facilities can maintain 24/7 operational reliability.
Detection of infectious diseases (COVID-19, HIV, HBV), oncology biomarkers, and genetic disorders in Tier-1 hospitals and private clinics.
On-site testing for African Swine Fever (ASF), Avian Flu, and livestock genetic screening to protect regional food security.
Rapid screening for Salmonella, Listeria, and GMO components in processing plants and international export ports.
DNA profiling and forensic specimen analysis for law enforcement and academic research institutions.
BioX Medical serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. We understand that global procurement involves complex logistics and regulatory hurdles. Therefore, we provide:
A: Our systems integrate advanced thermal Peltier modules with high-sensitivity optical fiber detection. Unlike many competitors, we offer an "Open System" approach, meaning our machines are compatible with reagents from any global manufacturer, giving labs ultimate flexibility.
A: Yes, our flagship models support up to 6 channels, allowing for the simultaneous detection of multiple targets (e.g., FAM, HEX, ROX, CY5, etc.) in a single tube.
A: All precision instruments are vacuum-sealed and packed in military-grade shock-absorbent cases. We perform a final 48-hour calibration test on every unit immediately before dispatch.
A: Absolutely. Our in-house software team can provide white-label software solutions, custom analysis algorithms, and LIS (Laboratory Information System) integration.
Our multidisciplinary team of engineers and laboratory specialists continuously invests in innovation. Comprehensive quality control procedures are implemented throughout design, manufacturing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
